Psychosis Due to a Medical Condition: Causes and Evaluation
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
New psychotic symptoms can sometimes be a sign of a medical problem affecting the brain or the rest of the body. A person may hear voices, see things others cannot see, develop beliefs that feel absolutely certain despite strong contradictory evidence, or become markedly disorganized. Those experiences require careful attention to both mental and physical health. When symptoms begin suddenly, accompany confusion or fever, follow a seizure or head injury, or occur with other neurological changes, a medical cause deserves urgent evaluation.
Psychosis due to a medical condition describes hallucinations or delusions attributable to the physiological effects of an identifiable illness. It is a clinical diagnosis reached through assessment of the person's symptoms, examination, medical history, investigation of alternative explanations, and evidence connecting the illness to the psychotic presentation. The presence of a physical illness beside psychosis does not itself establish causation. Merck Manual Professional Edition describes the relevant diagnostic distinction, while NICE's guideline on psychosis and schizophrenia requires medical assessment as part of comprehensive psychosis care.
This guide explains the clinical meaning of medically caused psychosis, the illnesses that may produce it, warning signs, how clinicians investigate the cause, how it differs from delirium and psychiatric psychotic disorders, what treatment depends on, and what patients and families can expect. It offers educational information for clinical conversations; diagnosis and investigation depend on individual medical evaluation.
What Does Psychosis Due to a Medical Condition Mean?
Psychosis is a collection of experiences and behaviors in which perception, thinking, or interpretation of reality may be substantially altered. A hallucination is a perception-like experience without the corresponding external stimulus, such as hearing speech when nobody is speaking. A delusion is a belief maintained with unusual conviction despite evidence that would ordinarily undermine it, assessed within the person's cultural and social context. Disorganized thinking may become apparent through speech that is hard to follow, and some presentations involve marked changes in behavior or movement. NIMH's Understanding Psychosis resource outlines this broader syndrome.
The diagnosis traditionally called psychotic disorder due to another medical condition concerns prominent hallucinations or delusions with evidence that a medical illness has caused them through a physiological pathway. Clinicians examine whether the medical condition is capable of producing the experience, whether timing and associated findings make causation plausible, and whether another psychiatric disorder, a medication or substance effect, or delirium better accounts for the presentation. The assessment may remain provisional until results and the clinical course clarify what is happening. Merck Manual provides an overview of this condition.
Schizophrenia is a distinct psychiatric disorder requiring its own diagnostic criteria and duration considerations; psychosis is a syndrome that also occurs in other psychiatric and medical conditions. Schizophrenia-spectrum conditions and medically caused psychosis therefore require different diagnostic reasoning, although specialist psychiatric care can be relevant to both. For the broader schizophrenia presentation, see our schizophrenia symptoms, diagnosis, treatment, and recovery overview.
A person can have hallucinations without meeting criteria for schizophrenia or for psychotic disorder due to another medical condition. Hallucinations can also occur during delirium, certain neurological illnesses, sleep transitions, medication effects, and other circumstances. Likewise, an unusual belief is not automatically a delusion; beliefs must be understood in their cultural, interpersonal, and clinical context.
When Psychosis May Signal a Medical Emergency
A new or rapidly changing psychotic presentation needs prompt medical assessment, especially when accompanied by altered consciousness, severe physical symptoms, or neurological findings. Call local emergency services or seek emergency department assessment for a person who has psychosis together with any of the following features. In the United States, call 911 for immediate danger; other countries use their local emergency number.
• Fever with severe headache, neck stiffness, rapidly increasing confusion, seizure, or unusual new movements, which can occur in encephalitis or other acute neurological illness.
• A sudden change in speech, facial movement, strength, vision, balance, or alertness, especially when stroke or an intracranial event is possible.
• Severe disorientation, fluctuating attention, fainting, inability to remain awake, major dehydration, difficulty breathing, or signs of low blood sugar or another serious systemic illness.
• Marked rigidity, prolonged immobility, refusal or inability to drink, autonomic instability, or potentially dangerous agitation suggesting catatonia or another acute syndrome.
• Imminent self-harm or suicide risk, inability to maintain immediate safety, or behavior that creates an immediate danger.
If someone is acutely confused, do not assume the explanation is a psychiatric illness. NICE delirium guidance identifies new or fluctuating changes in attention, cognition, perception, physical function, and social behavior as reasons for delirium assessment. Graus and colleagues' autoimmune encephalitis diagnostic approach00401-9) highlights the need for neurological assessment when brain inflammation is suspected.
Caregivers can improve immediate safety by staying calm, reducing environmental stimulation, removing accessible hazards where it is safe to do so, and giving emergency responders a concise medication list and symptom timeline. Avoid physically restraining someone unless directed by emergency personnel for immediate safety. Do not delay urgent evaluation to complete an online checklist, arrange a routine psychiatric visit, or wait for symptoms to disappear.
Medical Conditions That Can Cause Psychotic Symptoms
The differential diagnosis spans neurological, infectious, inflammatory, endocrine, metabolic, nutritional, vascular, and other systemic conditions. The relative likelihood depends heavily on age, medication exposures, immune status, the speed of onset, examination findings, and whether consciousness or attention is impaired. Reviews of secondary psychosis show why medical history, examination, and context-sensitive investigations belong alongside psychiatric assessment. See the 2023 systematic literature review by Dissaux and colleagues and the American Family Physician differential diagnosis review.
Neurological conditions
Epilepsy can be associated with unusual sensory experiences, perceptual disturbances, or psychotic episodes at particular points in the seizure course. Brief stereotyped episodes, loss of awareness, automatisms, an episode followed by confusion, or a seizure history may point toward neurological assessment and electroencephalography. A temporal association is informative but requires evaluation; an unusual smell or a brief visual image alone does not identify epilepsy. Merck Manual describes temporal lobe epilepsy among potential causes.
Stroke, traumatic brain injury, brain tumors, space-occupying lesions, and other structural brain conditions can alter cognition, perception, and behavior. Sudden focal neurological deficits increase concern about a vascular emergency, while progressive headaches, seizures, focal findings, or personality and cognitive changes can warrant directed structural imaging. The absence of such signs reduces the likelihood of some causes but does not categorically exclude them. Griswold and colleagues discuss these differential clues.
Parkinson disease and several neurocognitive disorders can be associated with hallucinations or delusions; visual experiences may be particularly prominent in some conditions. The assessment must distinguish symptoms associated with the neurological disease from delirium, medication effects, and environmental or sensory factors. Older age alone never establishes a neurodegenerative diagnosis, and these conditions have separate disease-specific diagnostic and treatment pathways. NIMH includes neurological illnesses of older age in its discussion of psychosis.
Multiple sclerosis, Huntington disease, and rarer inherited or acquired neurological syndromes occasionally involve psychiatric manifestations. Clinical clues such as movement abnormalities, visual or gait symptoms, progressive cognitive change, family history, or other physical findings help determine whether specialized testing is warranted. These examples illustrate diagnostic possibilities rather than a reason to test every person for every rare disorder. The AAFP differential review details this principle.
Autoimmune encephalitis and inflammatory diseases
Autoimmune encephalitis deserves particular attention because behavioral change and psychiatric symptoms can sometimes precede conspicuous neurological signs. Anti-NMDA receptor encephalitis, for example, may involve psychotic symptoms together with seizures, abnormal movements, language dysfunction, fluctuating consciousness, autonomic disturbances, or other evolving neurological findings. This is an important potentially treatable condition, but psychiatric symptoms alone are insufficient to diagnose it. Graus et al.'s consensus approach00401-9) proposes criteria based on the clinical syndrome, neurological examination, MRI, EEG, cerebrospinal fluid findings, and appropriately interpreted antibody studies.
A rapidly evolving syndrome with new seizures, dyskinesias, catatonic features, marked cognitive deterioration, autonomic instability, or reduced consciousness changes the urgency and scope of testing. Isolated anxiety, a single unusual perception, or an internet checklist does not establish autoimmune encephalitis. Serum-only antibody results can sometimes be misleading; specialist interpretation and clinical correlation matter. Graus and colleagues00401-9) provide the diagnostic framework, and the 2023 systematic review discusses workup in first-episode psychosis.
Systemic lupus erythematosus and other immune-mediated conditions can also affect the central nervous system. The clinician considers inflammatory symptoms, systemic findings, medication effects, and neurological results rather than treating an elevated nonspecific antibody result as proof that a psychotic episode has an autoimmune cause.
Infections and inflammatory brain disorders
Encephalitis, meningitis, HIV-associated neurological disease, neurosyphilis, and severe systemic infections can present with disturbances in behavior and thought. Fever, headache, neck stiffness, seizures, immunosuppression, rapidly changing cognition, and neurological deficits may heighten concern, although not every infection has a textbook presentation. In acute illness, psychotic experiences may arise within delirium rather than as a sustained psychotic disorder. Prompt assessment of infection-related red flags is central to safe care. AAFP and NICE delirium guidance discuss the diagnostic pathways.
Infectious testing follows clinical likelihood and risk factors. HIV or syphilis testing may be appropriate in a new psychosis assessment, with a clinician explaining why the tests are recommended. Lumbar puncture may be needed if encephalitis, meningitis, or another central nervous system process is suspected and it can be performed safely. Not every patient needs a spinal tap.
Endocrine and metabolic disturbances
Thyroid disorders, especially marked hyperthyroidism or severe hypothyroidism, can sometimes accompany psychotic symptoms. More urgent metabolic processes include hypoglycemia, extreme hyperglycemia, sodium or calcium disturbances, renal or hepatic failure, hypoxia, and other conditions that can impair brain function. Clinicians often identify these possibilities through vital signs, bedside glucose measurement, blood chemistry, and directed history. Severe metabolic disturbance frequently produces delirium, so the diagnostic label depends on the full syndrome. AAFP clinical review surveys common and uncommon metabolic causes.
Adrenal disorders and major hormonal disturbances are less common potential contributors. Clinical clues may include major changes in blood pressure or heart rate, characteristic physical changes, weight change, altered energy, weakness, and relevant medication history. A positive laboratory abnormality must be interpreted for severity, timing, and whether it actually explains the psychiatric presentation.
Acute intermittent porphyria and certain inborn errors of metabolism are unusual but important considerations when psychotic symptoms coincide with severe episodic abdominal pain, neuropathy, autonomic symptoms, characteristic family history, or other compatible signs. Testing is directed to the suspected condition, rather than used as a universal psychosis screen. Griswold et al. describe such diagnostic clues.
Nutritional and systemic causes
Vitamin B12 deficiency and other significant nutritional deficiencies may affect cognition, mood, and in some cases perception or belief formation. Malnutrition, poor absorption, restricted intake, and neurologic signs can make deficiency testing more relevant. Replacing a documented deficiency can be essential, although it should not be assumed to resolve all psychotic experiences. Sleep loss can intensify unusual perceptions and is also an important part of the history. NIMH notes sleep deprivation as a possible contributor; the AAFP review describes nutritional investigations.
Serious pain, organ failure, systemic inflammation, sensory impairment, and complex multi-illness states may interact with medication effects and vulnerability to delirium. Careful investigation asks how symptoms emerged over time and which findings can be treated rather than assigning every symptom to a single explanation prematurely.
Medications and Substances: An Essential Parallel Assessment
Many psychosis presentations require a detailed review of prescription medicines, recently changed doses, over-the-counter products, herbal products, and recreational substances. Corticosteroids, dopamine-enhancing drugs used for movement disorders, some anticholinergic medicines, and certain stimulants are recognized examples of exposures that may precipitate hallucinations, delusions, or altered mental status in susceptible circumstances. Substance intoxication and withdrawal can produce similar symptoms, sometimes through life-threatening delirium. The AAFP differential diagnosis review and NIMH describe these contributors.
This is a neighboring causal category rather than proof of psychosis due to another medical condition. A clinician may use a substance- or medication-induced psychotic disorder diagnosis when the evidence supports an exposure-related explanation, and may instead diagnose intoxication, withdrawal, or delirium when those conditions better explain the presentation. A medical illness and a medication effect can also coexist.
The medication history should record every agent, dose, start or stop date, recent changes, and the timing of the first symptoms. Do not abruptly stop prescribed medications on the basis of this article. Some withdrawals can be medically dangerous, and any taper or replacement must be planned by the treating clinician.
Clinical Clues That Increase Suspicion of a Secondary Cause
No single hallucination type, age cutoff, laboratory finding, or symptom pattern reliably divides medical from primary psychiatric psychosis. Suspicion rises when several clues point in the same direction. Medical history and clinical examination therefore carry more diagnostic weight than popular symptom lists. Dissaux et al. reviewed somatic differential diagnoses, while NICE CG178 specifies a broad medical and psychiatric assessment.
• Onset over hours or days, especially with fluctuations in alertness, attention, or orientation.
• First presentation at an atypical age or a markedly different course from earlier episodes, particularly when accompanied by neurological findings.
• Fever, pronounced headache, systemic illness, abnormal vital signs, recent trauma, or new seizures.
• New focal deficits, altered gait, involuntary movements, catatonic features, or unusually rapid cognitive decline.
• Recent medication changes, suspected intoxication or withdrawal, new endocrine symptoms, or substantial metabolic risk.
• An evolving constellation of psychiatric and neurological symptoms, especially when initial investigations do not explain a worsening course.
Visual hallucinations may be a useful clue in certain medical and neurological conditions, yet auditory hallucinations can also occur in medically caused psychosis, and visual hallucinations can occur in psychiatric disorders. Clinical context is decisive. A normal initial laboratory panel also cannot exclude every structural, inflammatory, or neurological condition.
The opposite caution matters as well: an established diagnosis of schizophrenia or another psychiatric disorder does not protect a person from infections, strokes, delirium, metabolic emergencies, or medication toxicity. A sudden departure from the person's usual mental state deserves medical reassessment.
Psychosis, Delirium, and Schizophrenia: How Clinicians Tell Them Apart
Delirium and medically caused psychosis
Delirium is an acute disturbance of attention and awareness, usually developing over a short period and tending to fluctuate. It may include disorientation, altered sleep–wake cycles, slowed responses, agitation, hallucinations, and changing alertness. Delirium commonly results from illness, medication effects, surgery, dehydration, or several interacting factors. The altered-attention syndrome is fundamental to the diagnosis, and treating its causes takes priority. NICE CG103 recommends the 4AT for appropriately trained assessors outside critical care; critical care settings use CAM-ICU or ICDSC.
Psychotic disorder due to another medical condition is considered when hallucinations or delusions are directly attributable to the physiological consequences of illness and are not exclusively explained by delirium. In practice, the early presentation may be ambiguous. A person can have a medical condition, delirium, and psychotic symptoms at the same time, and clinicians must describe the findings accurately while assessing the cause. Merck Manual and NICE delirium guidance explain the relevant frameworks.
Primary psychiatric psychosis
Schizophrenia involves a pattern of symptoms and longitudinal criteria assessed in context, with significant attention to differential diagnosis. Schizophreniform disorder, brief psychotic disorder, delusional disorder, and schizoaffective disorder have distinct criteria and clinical courses. Bipolar disorder or major depressive disorder can also involve psychotic symptoms, typically requiring an assessment of mood episodes and their relationship to psychosis. Those diagnoses are neither established nor ruled out by a single symptom. Our schizophrenia-spectrum guide provides the specific distinctions.
A clinician will consider whether a primary mood or schizophrenia-spectrum disorder best explains the pattern after reviewing medical, medication-related, and substance-related causes. Duration, characteristic mood changes, prior episodes, sleep, functional change, family history, and the evolving course all inform this judgment. Importantly, medically caused psychosis is not synonymous with a late-onset presentation, and primary psychiatric psychosis is not synonymous with a young adult presentation.
Why diagnostic categories sometimes change
An emergency physician may initially document acute altered mental status or unspecified psychosis, while a neurologist investigates suspected encephalitis and a psychiatrist assesses delusions or hallucinations. Later information—laboratory results, EEG, imaging, cerebrospinal fluid findings, medication history, and response to treating the underlying disease—may support a more specific diagnosis. Updating a provisional diagnosis as evidence develops is part of careful clinical practice.
People and families can request an explanation of the working diagnosis, the conditions being investigated, what findings would change the clinical plan, and when the diagnosis will be reviewed.
How Is Psychosis Due to a Medical Condition Evaluated?
Evaluation begins with two questions: is there an immediate medical or safety emergency, and what processes could plausibly cause the current mental-state change? A diagnostic workup is individualized. It should be broad enough to detect significant treatable causes while avoiding indiscriminate testing whose false-positive results may misdirect care. Both specialist judgment and shared decision-making matter. NICE CG178 calls for a comprehensive multidisciplinary assessment of psychiatric symptoms, medical history and examination, medication and substance exposure, coexisting conditions, and functional impact.
1. Establish a precise timeline
Clinicians ask when symptoms first appeared, whether the onset was sudden or gradual, how long they have lasted, whether they fluctuate through the day, and whether they followed illness, injury, a seizure, medication exposure, sleep loss, or changes in substance use. The history includes past episodes, psychiatric and neurological diagnoses, family history, prior functioning, recent travel or infection, and important medical conditions. A witness who knows the person's baseline can describe changes that the person experiencing symptoms may find difficult to report.
An accurate medication list includes nonprescription agents, supplements, recent dose changes, missed doses, and withdrawals. Any exposure or illness must fit the chronology before being assigned a causal role. A time relationship may suggest a cause but cannot prove it on its own.
2. Assess mental state, attention, cognition, and immediate risk
A mental status examination examines appearance, behavior, speech, thought processes, mood, perception, orientation, attention, memory, and insight. It also assesses whether the person can meet basic needs and make or participate in decisions about care. Clinicians ask directly, respectfully, and without judgment about suicidal thoughts, self-injury, frightening experiences, threatening commands, and perceived danger. Such questions are an ordinary safety assessment, not an assumption that psychosis entails violence. NIMH explains the need for timely professional care.
Because delirium can be missed when someone appears quiet or withdrawn, clinicians deliberately test attention and assess changes from baseline. Where delirium is suspected, tools such as the 4AT support detection, but the final diagnosis requires professional clinical evaluation. NICE delirium guidance provides this recommendation.
3. Perform physical and neurological examinations
Vital signs, temperature, oxygen saturation, hydration status, cardiac and respiratory findings, and bedside blood glucose can identify immediate physiological concerns. A focused neurological examination looks for changes in cranial nerves, strength, sensation, coordination, reflexes, gait, involuntary movement, and signs of meningeal irritation. The breadth of examination depends on presentation and stability. Fever, abnormal vital signs, or focal signs should direct the workup rather than being dismissed as anxiety. Griswold et al. outline this systematic approach.
The medical assessment also reviews sleep, nutrition, pregnancy when relevant, and chronic diseases. Physical symptoms deserve investigation even when the person already has a psychiatric diagnosis.
4. Select laboratory investigations according to risk
Frequently considered initial investigations in a new or otherwise unexplained presentation include complete blood count; electrolytes, kidney and liver indices, and glucose; thyroid testing; and carefully selected toxicology or medication testing. Calcium, vitamin B12, folate, inflammatory measures, infection screening, and other tests are added according to clinical features and local protocols. Bedside glucose should be checked promptly in an acutely unwell or confused person. The AAFP review describes a practical differential, and Dissaux et al. summarize available first-episode research.
Additional tests may address HIV, syphilis, autoimmune disease, metabolic disorders, nutrition, and endocrine conditions when history or examination supports them. Some reviews recommend a comparatively broad first-episode screen, but proposed panels are not universal mandates. False-positive antibody findings, background seropositivity, and incidental laboratory changes can be misleading. The usefulness of a test depends on pretest probability, its specificity, and whether the result will change care.
A urine drug screen has limitations: detection windows differ, common screens miss some substances, and a positive result does not independently establish that an exposure caused psychosis. Results must be interpreted alongside the medication and exposure history.
5. Decide when brain imaging is indicated
CT may be appropriate urgently when clinicians suspect intracranial bleeding, acute trauma, or another immediately actionable process. MRI is usually more informative for many structural, inflammatory, or subtle neurological disorders when the patient is stable and imaging is warranted. Indications may include focal neurological signs, new seizures, atypical presentation, cognitive deterioration, severe unexplained headaches, or suspected encephalitis.
The evidence about routine imaging in otherwise uncomplicated first-episode psychosis remains debated. A 2023 JAMA Psychiatry systematic review and meta-analysis estimated that 5.9% of patients with first-episode psychosis had MRI findings that changed clinical management or diagnosis, and the authors favored routine MRI. A subsequent JAMA Psychiatry correspondence questioned the strength of that recommendation. NICE CG178 refers to its technology appraisal that does not recommend structural neuroimaging routinely for all first-episode psychosis patients. These findings support individualized discussion of imaging benefits, clinical context, resources, incidental findings, and local guidance, rather than treating either universal scanning or universal avoidance as a settled rule.
A normal MRI does not rule out delirium, epilepsy, autoimmune encephalitis, metabolic illness, or every medically caused psychotic presentation. Conversely, an incidental brain imaging abnormality does not establish that it caused the symptoms.
6. Use EEG, lumbar puncture, and specialized tests when indicated
EEG is useful when seizures, nonconvulsive status epilepticus, or encephalopathy are suspected. Lumbar puncture with cerebrospinal fluid analysis may be needed for suspected meningitis, encephalitis, or other inflammatory and infectious conditions, after clinicians assess procedural safety. Autoimmune encephalitis evaluation can involve MRI, EEG, paired serum and cerebrospinal fluid antibody studies, and investigation for associated tumors when clinically appropriate. These investigations follow a neurologic diagnostic framework and should not be ordered solely because a patient reports hallucinations. Graus et al.00401-9) describe syndrome-based assessment.
The combination of changing symptoms, examination, and test results should be reassessed over time. If findings are conflicting or the clinical condition deteriorates, collaboration among emergency medicine, internal medicine, neurology, and psychiatry may be necessary.
How Strong Is the Evidence for a Medical Workup?
The recommendation to check medical causes of new psychosis is well established in clinical guidance. NICE explicitly includes a full physical examination and consideration of organic brain disorders and prescribed medications; NIMH likewise describes medical illnesses and medications as possible contributors. The exact optimal universal battery is less certain. Studies differ in patient selection, age, setting, baseline risk, and test thresholds.
A 2023 systematic literature review cataloged somatic causes and proposed a wide workup for first-episode psychosis. That publication is especially useful as a map of possible diagnoses, but the strength of evidence varies across individual tests, and the review's suggested breadth should not be converted into compulsory autoimmune panels for everyone. The 2023 MRI meta-analysis offers quantitative evidence, yet imaging selection still reflects disagreement among clinical recommendations.
The practical conclusion is firm: clinicians should actively search for medical explanations and choose investigations based on the person's presentation, with a low threshold for urgent neurological or medical assessment when red flags appear.
Treatment: Address the Cause and Support Safety
Treatment depends on the cause. A medical diagnosis may call for correction of a metabolic disturbance, treatment of infection, management of endocrine disease, seizure treatment, or specialist care for inflammation or structural neurological pathology. For example, suspected autoimmune encephalitis may require hospitalization, neurological consultation, and disease-specific therapy; treatment should follow the actual diagnosis rather than an internet hypothesis. When delirium is present, identifying and treating precipitating conditions is central. NICE delirium guidance and Graus et al.00401-9) outline relevant clinical pathways.
Antipsychotic medication may be considered for severe, distressing psychotic symptoms or dangerous agitation when clinically appropriate, but the choice, dose, duration, and monitoring depend on the medical situation. A sedating medicine can worsen some neurological or physiological problems; drug interactions, QT prolongation, movement side effects, falls, metabolic consequences, and sedation require attention. In some neurological diseases, sensitivity to dopamine-blocking medications changes prescribing decisions. Medication should be individualized and prescribed by a clinician, with ongoing reassessment as the medical illness is treated. NICE CG178 discusses antipsychotic baseline monitoring and shared treatment decisions.
Antipsychotics do not automatically correct an infection, seizure disorder, metabolic emergency, or inflammatory brain disease. Symptom relief should occur alongside investigation and disease-specific management. In catatonia, medication selection can be especially consequential, and urgent specialist assessment is necessary. The treating team should also assess hydration, sleep, nutrition, distress, and physical complications.
After medical stabilization, people may benefit from psychological support, family information, occupational rehabilitation, sleep recovery, and help rebuilding confidence and routines. A distressing psychotic episode can affect trust and functioning even when the underlying medical condition improves. Recovery-oriented care asks about the person's own priorities and examines both symptom change and quality of life. For the broader recovery framework, see the NIMH overview.
What Does Recovery and Prognosis Depend On?
Outcomes vary widely by cause, treatment timing, prior health, severity, complications, and the person's support needs. A reversible metabolic disturbance may resolve after targeted treatment; encephalitis can require lengthy treatment and rehabilitation; a neurological condition may need ongoing management. Some people recover from the acute psychotic experience and return to prior functioning, while others need longer follow-up for cognition, sleep, mood, neurological symptoms, or recurrent episodes.
A diagnosis should not be used to assign an inevitable future. When symptoms remain after an illness has been treated, clinicians reconsider whether there are residual medical effects, another coexisting condition, medication contributions, or a primary psychiatric disorder. A follow-up plan should name the responsible teams, warning signs, medication review, monitoring needs, and practical support.
Respectful language matters. Experiencing psychosis does not define a person's character or value. Family members and clinicians can discuss unusual beliefs and perceptions without ridicule, listen to associated distress, and seek collaborative treatment goals.
What Patients and Families Can Do During Evaluation
The most useful preparation is a short, accurate timeline rather than an attempt to decide the diagnosis before the appointment. Record first symptoms, their daily pattern, physical signs, recent illnesses and injuries, seizures or unusual movements, sleep changes, all medications and substances, and what has changed in daily functioning. Bring prior discharge summaries, relevant laboratory or imaging results, and a current medication list where available.
During a clinical visit, reasonable questions include: Which urgent causes have been ruled out? Could this be delirium? What is the reason for each blood test or scan? What findings would make you request EEG or cerebrospinal fluid testing? How will we interpret abnormal or borderline results? Who will explain the results? When should we return urgently? How will the mental-health and medical teams coordinate?
When responding to a person with psychotic experiences, acknowledge that the fear or confusion may be very real to them, ask what helps them feel safer, and offer concrete assistance with arranging care. You do not need to agree with a delusional belief in order to respect the person. A respectful approach protects trust while allowing assessment and treatment to proceed.
Frequently Asked Questions
Can a physical illness really cause hallucinations or delusions?
Yes. Certain neurological, infectious, endocrine, autoimmune, metabolic, and other medical conditions can cause hallucinations, delusions, or broader alterations in perception and thinking. Establishing that the illness actually caused the symptoms requires clinical evidence, not merely the simultaneous presence of two diagnoses. See Merck Manual.
Does a hallucination mean I have schizophrenia?
No. Hallucinations occur in several psychiatric, medical, medication-related, sleep-related, and neurological contexts. The clinical diagnosis depends on the pattern, duration, associated features, and differential assessment. NIMH explains these distinctions.
Can medical psychosis happen without confusion?
Yes. Some medically caused psychotic presentations involve relatively preserved attention and awareness; others occur during delirium, where fluctuating attention and consciousness are defining features. Clinicians need to evaluate the actual syndrome. Merck Manual and NICE CG103 help clarify the distinction.
Are visual hallucinations proof of a neurological cause?
No. They can increase suspicion in certain contexts, especially with neurological signs or new cognitive changes, but they do not establish the cause on their own. Auditory hallucinations likewise do not prove a primary psychiatric disorder. AAFP describes these clinical clues and their limits.
What blood tests are done for new psychosis?
The initial selection often addresses blood count, electrolytes, glucose, kidney and liver function, thyroid disease, and relevant exposures. Additional tests may be ordered for infection, nutritional deficits, inflammation, autoimmunity, or other suspected conditions. Exact choices depend on history, examination, urgency, and local protocols. AAFP offers an overview.
Does everyone with first-episode psychosis need an MRI?
There is no single universal recommendation. A 2023 meta-analysis found clinically relevant MRI abnormalities in approximately 6% of first-episode cases and argued for broader imaging, while other guidance supports selective imaging based on clinical suspicion. The decision should take account of neurological signs, urgency, accessibility, and specialist assessment. See Blackman et al. and NICE CG178.
When should autoimmune encephalitis be considered?
Concern increases when rapidly developing psychiatric symptoms occur alongside new seizures, abnormal movements, autonomic instability, significant cognitive decline, altered consciousness, or compatible neurological findings. It requires specialist evaluation; psychiatric symptoms or a serum antibody result alone do not establish it. Graus et al.00401-9) describe diagnostic criteria.
Can antipsychotic medication treat medical psychosis?
Antipsychotics sometimes help control severe symptoms while clinicians treat the cause, but they are not a substitute for medical diagnosis and treatment. Risks, contraindications, and the underlying neurological or physical condition shape individual prescribing. See NICE antipsychotic recommendations.
What if the first tests are normal?
A normal initial workup may lower suspicion for particular diagnoses, but it does not exclude every medical or neurological cause. Reassessment is appropriate if red flags develop, symptoms persist or change, or new examination findings emerge. Clinicians may recommend follow-up, targeted imaging, EEG, specialized testing, or psychiatric evaluation based on the full presentation.
Can a person recover completely?
Many causes are treatable, and some people return to their previous level of functioning. The outlook depends on the responsible illness, the timing and success of treatment, complications, and the need for rehabilitation or ongoing mental-health care. Individual prognoses should be discussed with the treating team.
Clinical Takeaway
A psychotic symptom is a clinical finding that calls for understanding its cause. A medically caused psychotic disorder is diagnosed when an identifiable illness plausibly and demonstrably explains the experience, after attention to delirium, medications, substance exposure, and primary psychiatric conditions. Sudden changes, fluctuating consciousness, fever, seizures, focal neurological signs, or major physiological disturbance require urgent medical evaluation. Careful assessment combines history, examination, appropriate investigations, treatment of the cause, and continuing psychiatric and practical support.
For further background on psychosis and its psychiatric differential, consult our schizophrenia overview and schizophrenia-spectrum disorders guide.
Related Articles
• Schizophrenia: Symptoms, Causes, Diagnosis, Treatment, and Recovery — broad clinical context for distinguishing schizophrenia from other causes of psychosis.
• Schizophrenia Spectrum Disorders: Types, Differences, and Clinical Diagnosis — differences among schizophrenia-spectrum clinical diagnoses.
• Schizophrenia OCD: What Is It? Fear of Developing Psychosis, Symptom Checking, and Reassurance Seeking — a distinct discussion of intrusive fears rather than confirmed psychosis.
References
Blackman, G., Neri, G., Al-Doori, O., et al. (2023). Prevalence of neuroradiological abnormalities in first-episode psychosis: A systematic review and meta-analysis. JAMA Psychiatry, 80(10), 1047–1054. https://doi.org/10.1001/jamapsychiatry.2023.2225.
Dissaux, N., Neyme, P., Kim-Dufor, D.-H., et al. (2023). Psychosis caused by a somatic condition: How to make the diagnosis? A systematic literature review. Children, 10(9), 1439. https://doi.org/10.3390/children10091439.
Dralle, B., & Morgan, R. J. (2024). Concerns regarding strength of conclusions in systematic review and meta-analysis of neuroradiological abnormalities in first-episode psychosis. JAMA Psychiatry, 81(1), 108. https://doi.org/10.1001/jamapsychiatry.2023.4393.
Graus, F., Titulaer, M. J., Balu, R., et al. (2016). A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology, 15(4), 391–404. https://doi.org/10.1016/S1474-4422(15)00401-900401-9).
Griswold, K. S., Del Regno, P. A., & Berger, R. C. (2015). Recognition and differential diagnosis of psychosis in primary care. American Family Physician, 91(12), 856–863. American Family Physician article.
Keshavan, M. S. (2025). Psychotic disorder due to another medical condition. Merck Manual Professional Edition. Merck Manual.
National Institute of Mental Health. (n.d.). Understanding psychosis. National Institutes of Health. NIMH publication.
National Institute for Health and Care Excellence. (2010; updated 2023). Delirium: Prevention, diagnosis and management in hospital and long-term care (CG103). NICE guidance.
National Institute for Health and Care Excellence. (2014; subsequently amended). Psychosis and schizophrenia in adults: Prevention and management (CG178). NICE guidance.